Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
The Oncologist|March 11, 2003
Cancer fatigue: the way forwardGregory Curt, Patrick G Johnston
The Oncologist|July 13, 2013
AZD1480: a phase I study of a novel JAK2 inhibitor in solid tumorsElizabeth R Plimack, Patricia M Lorusso, Patricia McCoon, et al.
BMC Cancer|March 8, 2017
A phase I dose-escalation study of selumetinib in combination with docetaxel or dacarbazine in patients with advanced solid tumorsPatricia M LoRusso, Jeffrey R Infante, Kevin B Kim, et al.
Investigational New Drugs|April 21, 2017
A phase I dose-escalation study of Selumetinib in combination with Erlotinib or Temsirolimus in patients with advanced solid tumorsJeffrey R Infante, Roger B Cohen, Kevin B Kim, et al.
Pageof 1